Drug-resistant tuberculosis on the increase in the UK

May 02, 2008

A changing population structure and ongoing migration have increased cases of drug resistant tuberculosis, according to a study published onbmj.com today.

The incidence of tuberculosis in England, Wales and Northern Ireland has been on the increase with more than 8000 cases reported in 2006. In addition, resistance to antituberculosis drugs has been increasing globally.

Of mounting concern is the increasing transmission of drug resistant tuberculosis among difficult to treat, marginalised groups in urban areas such as London, and the problems this could create for tuberculosis control.

Dr Michelle Kruijshaar and colleagues present the latest trends in resistance to antituberculosis drugs between 1998 and 2005 using data from the National Surveillance System, involving 28 620 confirmed cases of tuberculosis.

Overall, the researchers found that the proportion of cases resistant to any first line drug had increased from 5.6% to 7.9%. They report an increasing proportion of isoniazid resistance (6.9%) and small increases in rifampicin resistance (1.2%) and multidrug resistance (0.9%).

Importantly, outside London there was a significant increase in resistance to isoniazid. The authors suggest this reflects the increasing number of patients with tuberculosis who are not born in the UK. Analyses showed an increase in the number of cases in people from Sub-Saharan Africa and the Indian subcontinent that could be related.

In London, the rise in isoniazid resistance has been linked to an ongoing outbreak from 1999 that has involved over 300 cases to date. This outbreak has been associated with imprisonment and drug misuse and includes mainly the UK born population. The authors reinforce the importance of recognising symptoms early in this group.

They also note that the proportion of multidrug resistance showed a small increase (from 0.8% to 0.9%)—with the levels seen in the UK similar to those in other Western European countries—and suggest that most multidrug resistance cases occur due to problems with patient management rather than as a result of transmission within the UK.

These findings highlight the importance of early case detection by clinicians, rapid testing of susceptibility to drugs, additional support services to ensure that patients complete treatment, as well as continuous surveillance, and more help with tuberculosis control in countries with high incidence, conclude the authors.

The rising incidence of tuberculosis in the UK, combined with the rising proportion of resistant cases, increases the potential for onward transmission, warn the authors of an accompanying editorial.

James Lewis and Violet Chihota call for a range of strategies to be implemented including strengthening tuberculosis control and improving research into new diagnostics and drugs for multidrug resistant strains.

“Drug resistant tuberculosis in the UK cannot be controlled solely with local strategies —a global perspective is needed”, they conclude.

Source: British Medical Journal

Explore further: Screening test finds drugs that show promise against Ebola

add to favorites email to friend print save as pdf

Related Stories

Future batteries: Lithium-sulfur with a graphene wrapper

1 hour ago

What do you get when you wrap a thin sheet of the "wonder material" graphene around a novel multifunctional sulfur electrode that combines an energy storage unit and electron/ion transfer networks? An extremely ...

Recommended for you

Three weeks since last Ebola case in Mali: WHO

1 hour ago

Mali has not had a case of Ebola for three weeks, the World Health Organization said Wednesday, completing one of the two incubation periods the country needs to be declared free of the virus.

Migraine may double risk for facial paralysis

1 hour ago

Migraine headache may double the risk of a nervous system condition that causes facial paralysis, called Bell's palsy, according to a new study published in the December 17, 2014, online issue of Neurology, the medical journa ...

Anti-diabetic drug springs new hope for tuberculosis patients

8 hours ago

A more effective treatment for tuberculosis (TB) could soon be available as scientists have discovered that Metformin (MET), a drug for treating diabetes, can also be used to boost the efficacy of TB medication without inducing ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.